direct-to-consumer advertising of prescription drugs: the year in review
DESCRIPTION
Direct-to-Consumer Advertising of Prescription Drugs: The Year in Review. Kathryn J. Aikin, Ph.D. Division of Drug Marketing, Advertising and Communications, FDA DTC National April 27, 2006. Talk Outline. Major influences in 2005 The year in DTC What is next?. Requirements for Ads. - PowerPoint PPT PresentationTRANSCRIPT
![Page 1: Direct-to-Consumer Advertising of Prescription Drugs: The Year in Review](https://reader036.vdocuments.site/reader036/viewer/2022062720/568134ab550346895d9bbf6a/html5/thumbnails/1.jpg)
Direct-to-Consumer Advertising of Prescription Drugs:The Year in Review
Kathryn J. Aikin, Ph.D.Division of Drug Marketing, Advertising
and Communications, FDA
DTC NationalApril 27, 2006
![Page 2: Direct-to-Consumer Advertising of Prescription Drugs: The Year in Review](https://reader036.vdocuments.site/reader036/viewer/2022062720/568134ab550346895d9bbf6a/html5/thumbnails/2.jpg)
Talk Outline
Major influences in 2005 The year in DTC What is next?
![Page 3: Direct-to-Consumer Advertising of Prescription Drugs: The Year in Review](https://reader036.vdocuments.site/reader036/viewer/2022062720/568134ab550346895d9bbf6a/html5/thumbnails/3.jpg)
Requirements for Ads
Per FDA regulations issued in late 1960’s, ads: Must not be false or misleading Must present “fair balance” between benefits
and risk information Must disclose “material” facts in light of claims
made about product
![Page 4: Direct-to-Consumer Advertising of Prescription Drugs: The Year in Review](https://reader036.vdocuments.site/reader036/viewer/2022062720/568134ab550346895d9bbf6a/html5/thumbnails/4.jpg)
What Does this Mean?
Accurately communicate indication(s) including context for any claim Limitations on indication(s)
Relevant patient population Concomitant therapies/treatments
Likelihood of benefit(s) Communicate most important risks in a manner reasonably
comparable to benefits (presentation and language) Cannot omit important information
In plain language Ads must communicate an accurate and balanced picture of the drug product
![Page 5: Direct-to-Consumer Advertising of Prescription Drugs: The Year in Review](https://reader036.vdocuments.site/reader036/viewer/2022062720/568134ab550346895d9bbf6a/html5/thumbnails/5.jpg)
What Events Shaped 2005?
Reexamination of DTC advertising
PhRMA DTC Guidelines
![Page 6: Direct-to-Consumer Advertising of Prescription Drugs: The Year in Review](https://reader036.vdocuments.site/reader036/viewer/2022062720/568134ab550346895d9bbf6a/html5/thumbnails/6.jpg)
Calls for Limitations on DTC Ads
Congress
Some companies enact voluntary delay
![Page 7: Direct-to-Consumer Advertising of Prescription Drugs: The Year in Review](https://reader036.vdocuments.site/reader036/viewer/2022062720/568134ab550346895d9bbf6a/html5/thumbnails/7.jpg)
PhRMA DTC Guidelines
Follow the existing regulations
More disease awareness
No broadcast reminders
Voluntary pre-submission to DDMAC
Physician education pre-DTC
![Page 8: Direct-to-Consumer Advertising of Prescription Drugs: The Year in Review](https://reader036.vdocuments.site/reader036/viewer/2022062720/568134ab550346895d9bbf6a/html5/thumbnails/8.jpg)
2005 Ads
![Page 9: Direct-to-Consumer Advertising of Prescription Drugs: The Year in Review](https://reader036.vdocuments.site/reader036/viewer/2022062720/568134ab550346895d9bbf6a/html5/thumbnails/9.jpg)
The Doctor
![Page 10: Direct-to-Consumer Advertising of Prescription Drugs: The Year in Review](https://reader036.vdocuments.site/reader036/viewer/2022062720/568134ab550346895d9bbf6a/html5/thumbnails/10.jpg)
![Page 11: Direct-to-Consumer Advertising of Prescription Drugs: The Year in Review](https://reader036.vdocuments.site/reader036/viewer/2022062720/568134ab550346895d9bbf6a/html5/thumbnails/11.jpg)
![Page 12: Direct-to-Consumer Advertising of Prescription Drugs: The Year in Review](https://reader036.vdocuments.site/reader036/viewer/2022062720/568134ab550346895d9bbf6a/html5/thumbnails/12.jpg)
The Actor (or Celebrity)
![Page 13: Direct-to-Consumer Advertising of Prescription Drugs: The Year in Review](https://reader036.vdocuments.site/reader036/viewer/2022062720/568134ab550346895d9bbf6a/html5/thumbnails/13.jpg)
![Page 14: Direct-to-Consumer Advertising of Prescription Drugs: The Year in Review](https://reader036.vdocuments.site/reader036/viewer/2022062720/568134ab550346895d9bbf6a/html5/thumbnails/14.jpg)
The Conversation
![Page 15: Direct-to-Consumer Advertising of Prescription Drugs: The Year in Review](https://reader036.vdocuments.site/reader036/viewer/2022062720/568134ab550346895d9bbf6a/html5/thumbnails/15.jpg)
![Page 16: Direct-to-Consumer Advertising of Prescription Drugs: The Year in Review](https://reader036.vdocuments.site/reader036/viewer/2022062720/568134ab550346895d9bbf6a/html5/thumbnails/16.jpg)
What is Next?
![Page 17: Direct-to-Consumer Advertising of Prescription Drugs: The Year in Review](https://reader036.vdocuments.site/reader036/viewer/2022062720/568134ab550346895d9bbf6a/html5/thumbnails/17.jpg)
Disease Awareness Advertising
![Page 18: Direct-to-Consumer Advertising of Prescription Drugs: The Year in Review](https://reader036.vdocuments.site/reader036/viewer/2022062720/568134ab550346895d9bbf6a/html5/thumbnails/18.jpg)
![Page 19: Direct-to-Consumer Advertising of Prescription Drugs: The Year in Review](https://reader036.vdocuments.site/reader036/viewer/2022062720/568134ab550346895d9bbf6a/html5/thumbnails/19.jpg)
![Page 20: Direct-to-Consumer Advertising of Prescription Drugs: The Year in Review](https://reader036.vdocuments.site/reader036/viewer/2022062720/568134ab550346895d9bbf6a/html5/thumbnails/20.jpg)
Where to Find Recent Guidances
Consumer-Directed Broadcast Ads: http:// www.fda.gov/cder/guidance/1804fnl.htm
“Help-Seeking” and Other Disease Awareness Communications: http://www.fda.gov/cder/guidance/6019dft.pdf
Brief Summary: Disclosing Risk Information in Consumer-Directed Print Ads: http://www.fda.gov/cder/guidance/5669dft.pdf
![Page 21: Direct-to-Consumer Advertising of Prescription Drugs: The Year in Review](https://reader036.vdocuments.site/reader036/viewer/2022062720/568134ab550346895d9bbf6a/html5/thumbnails/21.jpg)
Other Online FDA Resources
General FDA information: http://www.fda.gov
DDMAC home page: http://www.fda.gov/cder/ddmac.htm
Untitled and Warning Letters: http://www.fda.gov/cder/warn/index.htm
Contact info: [email protected]